Cathie Wood Doubles Down: Mops Up Another $1.39 Million Worth Of Robinhood Stock Amid Trump Tariff Dip On Thursday, April 3, 2025, Cathie Wood-led Ark Invest purchased Robinhood stock worth $1.39 million amid a broader market slump.
Cathie Wood's Ark Invest Loads Up On Robinhood, Nvidia-Backed CoreWeave: Offloads Spotify, Roku Cathie Wood-led Ark Invest made substantial trades, buying Robinhood and CoreWeave shares and selling Roblox, Genius Sports, Roku, and Spotify shares.
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.
Why Is Repare Therapeutics Stock Trading Lower On Friday? Repare Therapeutics shares MYTHIC trial data, highlighting Lunre+Camo's tolerability and efficacy in gynecologic cancers with FDA guidance on next steps.
US Stocks Likely To Open Higher, Investors Eye Fed Policy Meet Next Week: Broadcom, RH, Costco In Focus U.S. stock futures advanced on Friday in premarket after declining on Thursday. The futures of all four major indices were trading higher.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday We're diving into the biggest pre-market stock movers for Wednesday will a look at all of the latest news happening this morning.
RPTX Stock Earnings: Repare Therapeutics Beats EPS, Beats Revenue for Q1 2024 RPTX stock results show that Repare Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + GemOx vs. Rituxan + GemOx.
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved.
